Director Shareholding

Finsbury Worldwide Pharm Tst PLC
5 July 2002

                                  SCHEDULE 11

          NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS

 1.      Name of company

Finsbury Worldwide Pharmaceutical Trust PLC

 2. Name of director

Professor Duncan Geddes


3)      Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-
beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18 or in
respect of a non-beneficial interest

Beneficial Holding

4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)

Smith & Williamson Nominees Limited

5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)


As in 2 above


6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary

Beneficial Holding

7) Number of shares/amount of
stock acquired

3,734

8) Percentage of issued class

0.009%

9) Number of shares/amount
of stock disposed

n/a

10) Percentage of issued class

n/a

11) Class of security

Ordinary shares of 25p each

12) Price per share

430p

13) Date of transaction

28 June 2002

14) Date company informed

4 July 2002

15) Total holding following this notification

20,000

16) Total percentage holding of issued class following this notification

0.05%


17) Any additional information

none

24) Name of contact and telephone number for queries


Faith Pengelly

Close Finsbury Asset Management Limited

Secretary

Tel: [phone]

5 July 2002



                      This information is provided by RNS
            The company news service from the London Stock Exchange